These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23887143)

  • 1. Adult and near-adult height in patients with severe insulin-like growth factor-I deficiency after long-term therapy with recombinant human insulin-like growth factor-I.
    Backeljauw PF; Kuntze J; Frane J; Calikoglu AS; Chernausek SD
    Horm Res Paediatr; 2013; 80(1):47-56. PubMed ID: 23887143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth response to rhIGF-I 80 microg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype.
    Azcona C; Preece MA; Rose SJ; Fraser N; Rappaport R; Ranke MB; Savage MO
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):787-92. PubMed ID: 10619985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing the child with severe primary insulin-like growth factor-1 deficiency (IGFD): IGFD diagnosis and management.
    Cohen J; Blethen S; Kuntze J; Smith SL; Lomax KG; Mathew PM
    Drugs R D; 2014 Mar; 14(1):25-9. PubMed ID: 24639006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severe primary IGF-1 deficiency using rhIGF-1 preparation - first three years of Polish experience.
    Petriczko E; Jackowski T; Horodnicka-Józwa A; Wikiera B; Noczyńska A; Korpal-Szczyrska M; Birkholz-Walerzak D; Małecka-Tendera E; Kalina-Fraska B; Kalina M; Barg E; Beń-Skowronek I; Szewczyk L; Hilczer M; Smyczyńska J; Stawerska R; Lewiński A; Ziora K; Bossowski A; Pietrewicz E; Pyrżak B; Kędzia A; Szalecki M; Kilian A; Walczak M
    Endokrynol Pol; 2019; 70(1):20-27. PubMed ID: 30351442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity.
    Chernausek SD; Backeljauw PF; Frane J; Kuntze J; Underwood LE;
    J Clin Endocrinol Metab; 2007 Mar; 92(3):902-10. PubMed ID: 17192294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pubertal Timing and Growth Dynamics in Children With Severe Primary IGF-1 Deficiency: Results From the European Increlex
    Bang P; Polak M; Perrot V; Sert C; Shaikh H; Woelfle J
    Front Endocrinol (Lausanne); 2022; 13():812568. PubMed ID: 35250870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential measurements of IGF-I serum concentrations in adolescents with Laron syndrome treated with recombinant human IGF-I (rhIGF-I).
    Breil T; Kneppo C; Bettendorf M; ; Müller HL; Kapelari K; Schnabel D; Woelfle J
    J Pediatr Endocrinol Metab; 2018 Aug; 31(8):895-902. PubMed ID: 29995632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant insulin-like growth factor (IGF)-I treatment in short children with low IGF-I levels: first-year results from a randomized clinical trial.
    Midyett LK; Rogol AD; Van Meter QL; Frane J; Bright GM;
    J Clin Endocrinol Metab; 2010 Feb; 95(2):611-9. PubMed ID: 19880790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment with recombinant insulin-like growth factor 1 (IGF-1) in a child with IGF-1 gene mutation.
    Concolino D; Muzzi G; Sestito S; Vega G; Bonapace G; Strisciuglio P
    Eur J Pediatr; 2010 Feb; 169(2):245-7. PubMed ID: 19517134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
    Backeljauw PF; Miller BS; Dutailly P; Houchard A; Lawson E; Hale DE; Reiner B; Sperling MA;
    Horm Res Paediatr; 2015; 83(4):268-79. PubMed ID: 25765099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R; Gunczler P
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effect of two doses of growth hormone for growth hormone deficiency. The Dutch Growth Hormone Working Group.
    De Muinck Keizer-Schrama S; Rikken B; Hokken-Koelega A; Wit JM; Drop S
    Arch Dis Child; 1994 Jul; 71(1):12-8. PubMed ID: 8067786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and safety of rhIGF1 therapy in patients with or without Laron syndrome.
    Bang P; Woelfle J; Perrot V; Sert C; Polak M
    Eur J Endocrinol; 2021 Feb; 184(2):267-276. PubMed ID: 33434161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of GnRH analogue on height potential in patients with severe growth hormone insensitivity syndrome treated with IGF-I.
    El Kholy M; Elsedfy HH
    J Pediatr Endocrinol Metab; 2011; 24(11-12):983-8. PubMed ID: 22308852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.
    Guevara-Aguirre J; Rosenbloom AL; Vasconez O; Martinez V; Gargosky SE; Allen L; Rosenfeld RG
    J Clin Endocrinol Metab; 1997 Feb; 82(2):629-33. PubMed ID: 9024266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Human Insulin-Like Growth Factor-1 Treatment of Severe Growth Failure in Three Siblings with STAT5B Deficiency.
    Muthuvel G; Al Remeithi SS; Foley C; Dauber A; Hwa V; Backeljauw P
    Horm Res Paediatr; 2024; 97(2):195-202. PubMed ID: 37586336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A two year observation of the process of applying recombinant IGF-1 to treat short stature in children with primary IGF-1 deficiency -- case reports of 3 patients.
    Petriczko E; Wikiera B; Horodnicka-Józwa A; Marcinkiewicz K; Szmit-Domagalska J; Kędzia A; Durzyńska J; Broniarczyk J; Gabryelczyk B; Noczyńska A; Walczak M
    Pediatr Endocrinol Diabetes Metab; 2011; 17(4):233-8. PubMed ID: 22248785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seven years of safety and efficacy of the recombinant human growth hormone Omnitrope in the treatment of growth hormone deficient children: results of a phase III study.
    Romer T; Saenger P; Peter F; Walczak M; Le Bouc Y; Khan-Boluki J; Berghout A
    Horm Res; 2009; 72(6):359-69. PubMed ID: 19844125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-I in growth and metabolism.
    Backeljauw P; Bang P; Dunger DB; Juul A; Le Bouc Y; Rosenfeld R
    J Pediatr Endocrinol Metab; 2010; 23(1-2):3-16. PubMed ID: 20432800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.